|
J Biol Chem, Vol. 274, Issue 42, 30094-30100, October 15, 1999
Exonuclease X of Escherichia coli
A NOVEL 3'-5' DNase AND DnaQ SUPERFAMILY MEMBER INVOLVED
IN DNA REPAIR*
Mohan
Viswanathan and
Susan T.
Lovett
From the Department of Biology and Rosenstiel Basic Medical
Sciences Research Center, Brandeis University,
Waltham, Massachusetts 02254-9110
 |
ABSTRACT |
DNA exonucleases are critical for DNA
replication, repair, and recombination. In the bacterium
Escherichia coli there are 14 DNA exonucleases including
exonucleases I-IX (including the two DNA polymerase I exonucleases),
RecJ exonuclease, SbcCD exonuclease, RNase T, and the exonuclease
domains of DNA polymerase II and III. Here we report the discovery and
characterization of a new E. coli exonuclease, exonuclease
X. Exonuclease X is a member of a superfamily of proteins that have
homology to the 3'-5' exonuclease proofreading subunit (DnaQ) of
E. coli DNA polymerase III. We have engineered and purified
a (His)6-exonuclease X fusion protein and characterized its
activity. Exonuclease X is a potent distributive exonuclease, capable
of degrading both single-stranded and duplex DNA with 3'-5' polarity.
Its high affinity for single-strand DNA and its rapid catalytic rate
are similar to the processive exonucleases RecJ and exonuclease I. Deletion of the exoX gene exacerbated the UV sensitivity of
a strain lacking RecJ, exonuclease I, and exonuclease VII. When
overexpressed, exonuclease X is capable of substituting for exonuclease
I in UV repair. As we have proposed for the other single-strand DNA
exonucleases, exonuclease X may facilitate recombinational repair by
pre-synaptic and/or post-synaptic DNA degradation.
 |
INTRODUCTION |
Examination of multiple sequence alignments by both BLAST (1) and
hidden Markov model (2) have helped define a large family of proteins
that share sequence homology with the 3'-5' exodeoxyribonuclease domain
of DNA polymerases. The proofreading subunit of Escherichia
coli DNA polymerase III, encoded by dnaQ, is the
archetypal member of this family. Other family members include the
bacterial proteins RNase T, RNase D, exonuclease I (ExoI),1 oligoribonuclease
(3), the Saccharomyces cerevisiae PAN2 protein, and the
human Werner syndrome protein (WRN) (1, 2, 4). These proteins share a
conserved tripartite set of "Exo" motifs containing negatively
charged aspartate and glutamate residues (5). These hallmark residues
can be visualized in the crystal structure of the Klenow (proofreading)
subunit of E. coli DNA polymerase I to coordinate two
divalent cations that catalyze DNA phosphodiester bond cleavage (6-9).
Comparison of the crystal structures of the Klenow fragment and
bacteriophage T4 DNA polymerase suggests that the Exo motifs are
diagnostic of functional conservation, since both proteins share the
same active site structure despite the lack of sequence identity
outside of the Exo motifs (2, 10). Presumably, other proteins that
share these motifs adopt a catalytic site structure and mechanism of
action similar to the polymerase exonuclease domain.
It has recently been demonstrated that the Werner syndrome protein
(WRN) has a 3'-5' DNA exonuclease activity (11-13). Originally identified as a 3'-5' RecQ-like DNA helicase (14-16), the Werner syndrome protein also has an N-terminal DnaQ-like nuclease domain (17,
18). WRN possesses a weak exonuclease activity with specificity for the
3'-ending recessed strand of a partial DNA duplex but is unable to
degrade single-strand DNA alone (12).
We recently reported that RNase T of E. coli, previously
described as a 3'-5' ribonuclease (19-21), also possessed a potent 3'
to 5' distributive single-strand (ss) DNA-specific exonuclease activity
(22). When overexpressed, RNase T was capable of complementing DNA
repair defects caused by a deficiency in E. coli Exo I. Unlike exonucleases associated with DNA polymerase, which can degrade from the 3' end of double-strand (ds) DNA molecules, RNase T had no
activity on dsDNA substrates (22). Clearly, the architecture of
proteins within the DnaQ superfamily allows for different modalities of
function, since the same active site configuration can be used to
accommodate various substrates (ssDNA, dsDNA, RNA) while retaining the
3'-5' polarity of degradation.
In addition to the bacterial members of the DnaQ superfamily listed
above is an open reading frame of unknown function designated yobC (also known as o220 and b1844) at 41.5 min on the
E. coli chromosome. We have cloned, overexpressed, and
characterized the protein product of this gene. Overexpression of this
gene concomitantly induces high levels of a DNase activity on both
ssDNA and dsDNA. We have renamed this open reading frame
exoX and the native 25-kDa protein product exonuclease X
(ExoX). We have purified a (His)6-ExoX fusion protein to
homogeneity and characterized its nuclease activity on various DNA
substrates. ExoX is an extremely potent 3' to 5' distributive nuclease
capable of degrading 40-kilobase bacteriophage T7 ssDNA and dsDNA to
completion. Its affinity for ssDNA ends is greater than for dsDNA, and
it appears to have no affinity for RNA. When overexpressed, ExoX, like
RNase T (23), is capable of substituting for ExoI in vivo,
as measured by its ability to increase the UV survival of an
ExoI-deficient strain. A mutation in exoX did not by itself
cause sensitivity to UV but strongly augmented the UV sensitivity of a
strain deficient in ssDNA exonucleases RecJ, ExoI, and ExoVII.
 |
EXPERIMENTAL PROCEDURES |
Plasmid Constructions
The exoX gene was amplified by PCR using
Pfu polymerase (Stratagene Inc.) from wild type E. coli strain MG1655 genomic DNA using primers
5'-CGGAATTCTAAGGAGGGATCCATGTTGCGCATTATC-3' and
5'-GCTCTAGACTAAGTATTTTCCAG-3' and buffer conditions recommended by the
manufacturer. Primers were annealed to the genomic DNA at 50 °C for
30 s and extended for 2 min at 72 °C; 25 cycles of PCR were
performed. The PCR product was subsequently digested with restriction
endonucleases EcoRI and XbaI and ligated into the
compatible sites of pBSSK (Stratagene Inc.), producing
pExoX. Sequence analysis verified the construct was error-free.
The EcoRI-XbaI fragment from pExoX was cloned
into compatible sites within pBSKS (Stratagene Inc.)
creating pExoXKS . Plasmid pExoXfs, a derivative of
pExoXKS with a frameshift mutation 171 base pairs
downstream from the initiation codon of exoX, was
constructed by cleavage of pExoXKS DNA with restriction
endonuclease NcoI, "fill-in" synthesis with Klenow
fragment (DNA polymerase I), and blunt end DNA ligation. An
exoX (His)6-tagged gene fusion was constructed
by cloning the 693-base pair BamHI-SacI fragment
of pExoX into the same sites within pET28a(+) (Novogen), producing the
plasmid pExoX-His.
A 2,919-base pair region of the E. coli chromosome
containing the exoX gene was amplified by PCR using primers
beginning 1,088 base pairs upstream (5'-GGGAATTCGTACCCGTATGCGTGATG-3')
and 1,167 base pairs downstream (5'-GGTCTAGACGAGGATCATCAATTCCGG-3') of
exoX. The PCR was performed using Turbo Pfu
polymerase (Stratagene, Inc.) in buffer conditions recommended by the
manufacturer. Primers were annealed to MG1655 E. coli
genomic DNA at 60 °C for 30 s and extended for 3 min at
72 °C; 25 cycles of PCR were performed. The PCR product was digested
with XbaI and EcoRI and ligated into compatible
sites within the Litmus 29 vector (New England Biolabs Inc.), creating
the plasmid pExoXFlank.
A precise deletion of the exoX open reading frame from the
plasmid pExoXFlank was performed by PCR. The primers utilized for the
PCR flanked exoX and were oriented to replicate the entire plasmid except for the exoX open reading frame. Both
primers; 5'-GGGGGCGGCCGCGGCATGCTCCAGGCCG-3' and
5'-GGGGGCGGCCGCTCCGCAGGCGTAGCGGG-3' contained NotI
sites at the primer 5' terminus. The PCR was performed as above except
that primer annealing was at 45 °C, and extensions were performed
for 6 min. The resulting 5-kb PCR product was treated with
DpnI to remove any original methylated template DNA and then digested with NotI and ligated to a 2.1-kb NotI
fragment from plasmid pCK155 (24) containing a Tn5 npt gene,
which confers kanamycin resistance. Flanking npt on both
sides are 140-base pair resolution sites from the broad host range
plasmid RP4 multimer resolution system, which allows for the precise
excision of npt (24). The ligation was transformed by
electroporation into XL1-Blue (Stratagene Inc.) cells selecting
kanamycin-resistance. The resulting plasmid pExoX had a complete
deletion of exoX and a 2.1-kilobase insertion as verified by
restriction analysis.
Strains
For Protein Expression--
STL2350 (xonA2
recJ284::Tn10 (xseA-guaB)
zff-3139::Tn10kan) was used for ExoX protein
expression. Plasmid pTJH30 (25), carrying a heat shock-inducible T7 RNA
polymerase, was introduced into STL2350 by transformation (26) and
selection for chloramphenicol resistance. For protein-labeling
experiments pExoX or pBSSK were transformed into
STL2350/pTJH30 cells selecting ampicillin and chloramphenicol
resistance. Strain STL4239 is the pTJH30/pExoX transformant of STL2350.
STL2329 ( DE3 sbcB15 recJ284::Tn10 endA (xth-pncA)gal thi) (27) and BL21 (E. coli B DE3
F dcm ompT hsdS(rB
mB ) gal), both carrying a chromosomally
integrated
isopropyl-1-thio- -D-galactopyranoside-inducible T7 RNA
polymerase gene (27), were used to express and purify a
NH2-(His)6-tagged ExoX fusion protein expressed
from plasmid pExoX-His. For protein-labeling experiments, pExoX-His or
pET28a(+) were transformed into STL2329, selecting kanamycin resistance.
Construction of exoX Null Mutant--
pExoX was transformed
into the E. coli strain JC7623 (28) (recB recC sbcB
sbcC) by electroporation and grown nonselectively overnight.
Kanamycin-resistant and ampicillin-sensitive isolates were analyzed by
Southern blot (29) and were found to have the appropriate
deletion/insertion at the exoX locus. One such isolate, STL4525 ( exoX1::npt recB recC sbcB sbcC), was
used as a donor for further strain constructions by
P1virA-mediated transductions (Ref. 30 and see below). With
the exception of STL2329 and STL4525, all strains designated STL were
derived from BT199 and carry additional genetic markers
(F  thi-1 (gpt-proA)62
thr-1 leuB6 kdgK51 rfbD1 ara-14 lacY1 galK2 xyl-5 mtl-1 tsx-33
supE44 rpsL31 rac ).
For UV Survival Assays--
pExoXKS, pExoXfs, and
pBSKS were transformed (26) into either STL2701
( xonA300::cat (xseA-guaB)
zff-3139::Tn10kan
recJ2052::Tn10kan) or STL2348
( (xseA-guaB) zff-3139::Tn10kan
recJ284::Tn10, selecting ampicillin. In
addition, various isogenic exonuclease-deficient mutants in the BT199
genetic background (listed in Fig. 7) were assayed for UV survival. The
mutant alleles used in the construction of the various
exonuclease-deficient strains were: exoX1::npt, for ExoX; xonA300::cat, for ExoI;
recJ284::Tn10 for RecJ; and xseA18::amp for ExoVII. Details of the
construction of these strains will be published elsewhere and are
available by request from the authors.
UV Survival Assays
Single colonies were grown in LB or LB + ampicillin (for strains
containing plasmids) liquid medium to exponential stage
(A600 = 0.4-0.5), serially diluted in 56/2
buffer (60 mM Na2HPO4, 40 mM
KH2PO4, 0.02% MgSO4·7H2O, 0.2%
(NH4)2SO4, 0.01%
Ca(NO3)2·4H2O, 0.5 µM
FeSO4), and plated on LB or LB + ampicillin plates. Plates were
immediately irradiated with varying doses of UV (254 nm) irradiation
and incubated at 37 °C in the dark overnight. Total viable cells
were determined from serial-diluted unirradiated cells.
Protein Expression and Analysis
ExoX protein expression was induced from the T7 10 promoter
of pExoX by 42 °C heat shock induction of the T7 RNA polymerase gene
on plasmid pTJH30. T7 promoter-mediated expression of the (His)6-ExoX fusion protein from plasmid pExoX-His was
induced by the addition of
isopropyl-1-thio- -D-galactopyranoside (1 mM) to STL4337 (pExoX-His transformant of STL2329). Culture growth, [35S]methionine protein labeling in the presence of
rifampicin and crude extract preparations for both proteins were
performed as described previously (25). Protein concentrations were
measured by the method of Bradford (31) with standard reagent
(Bio-Rad) and bovine serum albumin (BSA) as standard. All
proteins were resolved by 15% SDS-polyacrylamide gel electrophoresis
(32) and visualized by Coomassie stain and/or autoradiography.
Purification of His6-ExoX
All steps were performed at 4 °C using ultrapure reagents.
Buffer A contained 50 mM Tris-HCl (pH 7.5), 200 mM NaCl, and 1 mM dithiothreitol. Buffer B
contained 10% glycerol, 20 mM Tris-HCl (pH 8.0), 500 mM NaCl, 25 mM imidazole, and 1 mM
-mercaptoethanol. Buffer C contained 10% glycerol, 20 mM Tris-HCl (pH 7.5), 1 mM EDTA, and 1 mM dithiothreitol (DTT). STL4533 (pExoX-His transformant of
BL21) was cultured at 37 °C in 34 liters of LB + Km to an
A600 of 0.6, then induced with 1 mM
isopropyl-1-thio- -D-galactopyranoside for 1 h.
Cells were harvested and frozen as described previously (33) in a
volume of 700 ml. A crude extract was prepared by lysing cells in 10%
sucrose, 50 mM Tris-HCl (pH 8.0), 50 mM NaCl, 5 mM MgCl2, 1 mM DTT, 1 mM EDTA, and 1 mg/ml lysozyme for 1 h on ice. Three
cycles of freeze/thawing (10 min 37 °C, 10 min 0 °C) were
performed before a supernatant was obtained by high speed centrifugation at 130,000 × g for 20 min. The crude
extract (700 ml, 1.8 g of protein) was adjusted to 200 mM NaCl and 5 mM imidazole before adding 15 ml
of Ni2+-nitrilotriacetic acid-agarose resin (Qiagen)
equilibrated in Buffer A. The resin and extract slurry was allowed to
mix for 8 h with stirring at 4 °C. The resin was washed by
repeated low speed centrifugation and resuspension in 175 ml of Buffer
A, 85 ml of Buffer B, and finally with 50 ml of Buffer C + 200 mM NaCl. Proteins were eluted from the resin with 35 ml of
Buffer C + 500 mM NaCl + 400 mM imidazole. The
resulting fraction (6.0 mg of protein) was concentrated to 10 ml using
a Centriprep 10 (Amicon) cartridge and then dialyzed against 2 1-liter
changes of Buffer C. This fraction was then applied to a 0.5-ml dsDNA
cellulose column equilibrated in Buffer C + 25 mM NaCl and
washed with 10 ml of Buffer C. Bound proteins were eluted in a single
step to Buffer C + 500 mM NaCl. Fractions containing
nuclease activity were pooled and dialyzed overnight against 0.5 liters
of 60% glycerol, 500 mM NaCl, and 1 mM DTT,
and then again against 60% glycerol, 1 mM DTT, 1 mM EDTA. The purified protein (0.75 mg at 0.41 mg/ml) was
stored at 20 °C.
DNA Substrates and DNase Assays
Uniformly labeled bacteriophage T7 [3H]DNA with a
specific activity of 2.5 × 104 cpm/nmol of nucleotide
was prepared as described previously (33) using
[3H]thymidine (NEN Life Science Products). 3' end-labeled
substrate was generated by Klenow fragment fill-in synthesis of
HindIII-digested pBSSK DNA with
[32P]dATP. 5' end-labeled substrate was generated from
HindIII-digested pBSSK DNA, treated with
shrimp alkaline phosphatase, and phosphorylated with T4 polynucleotide
kinase and [ -32P]ATP. Both 3' and 5' end-labeled
substrates were purified by G-50 Sephadex quick spin column (Roche
Molecular Biochemicals). Unless otherwise stated, enzyme assays
employed 0.5 µg of T7 [3H]DNA (1.5 nmol) or 0.5 µg
(0.5 pmol of ends) of 3' or 5' end-labeled substrate. For ssDNA assays,
substrates were incubated for 5 min at 100 °C then quenched on ice.
Standard reactions contained 10 mM Tris-HCl (pH 8.0), 10 mM MgCl2, 1 mM NaCl, and 2 mg/ml
BSA in 50 µl (for T7 substrates) or 30 µl (for end-labeled
substrates). Competition assays were performed with 50 ng (50 fmol) of
3' end-labeled substrate, varying the amount of either single-strand or
double-strand cold competitor DNA. Competition experiments using RNA
competitors utilized E. coli tRNA XXI (Sigma) and Torula
yeast RNA (molecular mass range 3 × 103-4 × 104 g/mol, Sigma). Both RNAs are used by Sigma as
ribonuclease assay substrates. Cold RNA stocks were prepared before
each competition experiment in cold sterile water. The
A260 of the RNA stocks was determined
immediately before use to verify the optical density provided by the
manufacturer and to ensure that noticeable degradation had not
occurred. When required, protein samples were diluted in a buffer
containing 60% glycerol, 10 mM Tris-HCl (pH 8.0), 1 mM DTT, and 1 mM EDTA. Sample incubation,
trichloroacetic acid precipitation, and soluble count determination
were performed as described previously (34). One unit of DNase activity
with T7 DNA substrate corresponds to the release of 1 nmol of
acid-soluble product in a 20-min reaction at 37 °C.
For agarose gel electrophoresis assays, 0.5 µg (0.5 pmol) of either
3' or 5' 32P end-labeled ssDNA substrate was incubated with
various amounts of (His)6-ExoX protein. Reactions were
quenched at various time points on ice by the addition of EDTA to 5.0 mM. Standard assay conditions were employed, except that
BSA was omitted to allow DNA electrophoresis without further
manipulation of the samples after the reactions were quenched. ssDNA
substrate samples were boiled for 5 min and cooled on ice before
loading onto a 1.0% agarose-NA gel (Amersham Pharmacia Biotech);
double-strand substrates were loaded directly onto the gels. Gels were
run at 80 V for 45 min in Tris acetate + EDTA buffer (32), dried at
80 °C for 30 min, and exposed to film.
Enzymes and Antibiotics
Shrimp alkaline phosphatase was obtained from Amersham Pharmacia
Biotech. Lysozyme was obtained from U. S. Biochemical Corp. All other
enzymes were obtained from New England Biolabs, Inc. The antibiotics
ampicillin, kanamycin, and chloramphenicol were used at 100, 60, and 15 µg/ml, respectively.
 |
RESULTS |
Overexpression and Purification of a DNase Activity Associated with
Exonuclease X--
The E. coli open reading frame
designated yobC, hereafter known as exoX, was
amplified by PCR and cloned directionally into pBSSK ,
placing its expression under T7 promoter control. Induction of
exoX expression from the T7 promoter of pExoX led to the
production of a single 25-kDa protein, consistent with the expected
molecular mass of the protein (Fig.
1A, lane 4). The
25-kDa protein was absent in uninduced extracts (Fig. 1A,
lane 3) and from cells carrying vector only (Fig.
1A, lane 2). Crude extracts prepared from these
induced cells were tested for DNase activity using uniformly
3H-labeled T7 DNA substrates. Strains induced for
expression of exoX exhibited a 150-fold increase in ssDNase
activity and a 280-fold increase in dsDNase activity compared with
cells carrying vector alone (Table I).
Both ssDNase and dsDNase activities were
Mg2+-dependent, as no increase in activity was
noted in the absence of the divalent cation (data not shown).

View larger version (42K):
[in this window]
[in a new window]
|
Fig. 1.
Expression, labeling and purification.
Protein expression, 35S-labeling and SDS-polyacrylamide gel
electrophoresis were performed as described under "Experimental
Procedures." [35S]Methionine-labeled whole cells
extracts are shown (panel A) in the following order:
lanes 1 and 2, pBSSK ; lanes
3 and 4, pExoX; lanes 5 and 6,
pET28a(+); lanes 7 and 8, pExoX-His.
Odd- and even-numbered lanes are from uninduced
and induced cells, respectively. Labeling experiments were performed in
the presence of rifampicin to inhibit expression from E. coli RNA polymerase. Each fraction from the purification of
(His)6-ExoX was resolved by electrophoresis through a 15%
SDS-polyacrylamide electrophoresis gel and stained with Coomassie Blue
(panel B). The SDS-polyacrylamide gel shown in panel
B contains crude extracts from cells induced for expression of the
(His)6-ExoX fusion protein from plasmid pExoX-His and
pooled protein fractions from the subsequent purification steps on
nickel (nitrilotriacetic acid (NTA))-agarose and dsDNA cellulose
matrices.
|
|
View this table:
[in this window]
[in a new window]
|
Table I
Mg2+-dependent DNase activity associated with ExoX
or (His)6-ExoX overexpression
Nuclease assays were performed using crude extracts prepared from cells
carrying the indicated plasmids. Cells were induced for protein
expression 20 min before assay. Assays were performed in the presence
of Mg2+ using both single-strand and double-strand T7
[3H]DNA substrates. One unit of DNase corresponds to the
release of 1 nmol of acid-soluble product in a 20-min reaction at
37 °C. Results are the average of two determinations.
|
|
An N-terminal (His)6-tagged ExoX protein fusion was
constructed using the pET28a(+) vector (Novogen).
(His)6-ExoX protein was expressed from the T7 promoter on
plasmid pExoX-His (Fig. 1A). Crude extracts prepared from
induced cells carrying pExoX-His were tested for DNase activity.
Strains induced for expression of (His)6-ExoX exhibited a
47-fold increase in ssDNase activity and a 170-fold increase in dsDNase
activity compared with cells carrying vector alone (Table I).
Comparison of uninduced levels of expression between the pET28a(+)
vector and pExoX-His revealed a basal level of expression of the
(His)6 fusion protein without induction of the T7 promoter.
Upon induction, increased expression of two
[35S]methionine-labeled proteins was noted. The identity
of the second band is unknown; however, it did not appear (Fig.
1A, lane 4) when the native protein was expressed
in a different strain background.
The (His)6-ExoX protein was overexpressed in E. coli strain BL21 and was purified using nickel-agarose
chromatography (Fig. 1B). Three high molecular weight
contaminants and a lower molecular weight protein were removed by dsDNA
cellulose affinity chromatography. The identity of the abundant lower
molecular weight band is not known; however, it may be a proteolytic
product of the (His)6-ExoX protein, since it bound to the
Ni2+-nitrilotriacetic acid resin yet failed to bind dsDNA
cellulose affinity column. Furthermore, the protein that bound to the
dsDNA cellulose column had significant nuclease activity, whereas the flow-through fraction from the dsDNA cellulose column containing the
lower molecular weight protein had nearly none. The purified protein
was analyzed by mass spectrometry and was determined to have a
molecular mass of 28,552 mass units. The molecular mass determined by
mass spectrometry is commensurate with the expected mass of the fusion
protein by amino acid sequence.
Properties of the DNase Activity of Exonuclease X--
Purified
(His)6-ExoX was used to determine optimal conditions for
ssDNase activity. ExoX showed optimal activity at pH 8.0 in the
presence of Mg2+ (Fig.
2A). Similar to other
nucleases, the ssDNase activity of ExoX was dependent upon the presence
of the divalent cation Mg2+; no detectable degradation was
seen in its absence or in the presence of Mn2+ (Fig.
2B). BSA enhanced the ssDNase activity of ExoX (Fig.
2C). The ssDNase activity of ExoX was enhanced with low salt
concentrations, but above 5 mM salt, the activity decreased
with increasing concentration (Fig. 2D). The addition of the
sulfhydryl reducing agent, DTT (1-5 mM), did not alter
levels of ssDNase activity (data not shown).

View larger version (14K):
[in this window]
[in a new window]
|
Fig. 2.
Optimization of ExoX activity. T7
nuclease assays were performed altering Tris-HCl buffer pH (panel
A), MgCl2 concentration (panel B,
black bars), MnCl2 in the absence of magnesium
(panel B, open bars), BSA (panel C),
NaCl (panel D). The 100% relative activity corresponds to
0.5 nmol of acid-soluble nucleotides in panels A and
C and 0.8 nmol in panels B and D.
Nuclease assays shown in panel A were done at 1 mg/ml BSA.
Assays in panel C were done at pH 8.5. All other assays were
done at standard conditions described under "Experimental
Procedures," varying the noted components.
|
|
In reactions with denatured bacteriophage T7 DNA (40 kb in length), 1 ng (34 fmol) of purified (His)6-ExoX linearly degraded 35%
of the total DNA (0.5 µg, 1.5 nmol in nucleotides) in 20 min. The
addition of 10 ng of protein resulted in 100% of the ssDNA substrate
being degraded (Fig. 3A).
Similarly, in reactions with T7 dsDNA, 5 ng (0.17 pmol) of purified
(His)6-ExoX linearly degraded 30% of the total DNA in 20 min, and the addition of 40 ng (1.4 pmol) of (His)6-ExoX
resulted in 100% of the dsDNA substrate being degraded (Fig.
3B). Using data points in the linear range of T7 DNA
degradation from Fig. 3, the calculated rate of nucleotide release/protein monomer is 800 nucleotide/min for ssDNA, and 150 nucleotides/min for dsDNA. From its ability to degrade T7 DNA completely, we conclude that ExoX has little or no specificity for DNA
sequence or structure. No endonuclease activity was observed in
reactions with X174 circular ssDNA, supercoiled dsDNA, or relaxed
dsDNA, suggesting that the DNase activity of ExoX is exonucleolytic and
not endonucleolytic in nature (data not shown). Electrophoretic analysis of end-labeled reaction products (discussed below) also support this conclusion.

View larger version (15K):
[in this window]
[in a new window]
|
Fig. 3.
Time course of degradation of either
denatured single-strand (panel A) or double-strand
(panel B) T7 DNA. The amounts of purified
(His)6-ExoX protein present in each reaction are indicated.
(His)6-ExoX has a specific activity of 6.5 × 105 units/mg on ssDNA and 1.0 × 105
units/mg on dsDNA.
|
|
Using uniformly labeled T7 ssDNA as substrate, the extent of ssDNA
degradation was determined for a substrate concentration range of
0.2-3.0 nM with 80 ng/ml (2.8 nM monomer) of
(His)6-ExoX in 5-min reactions using standard buffer
conditions. A Lineweaver-Burk plot produced a Km of
1.7 nM and a Vmax of 50 nmol of nucleotide/min/mg of protein for the degradation of 40 kb of ssDNA molecules (data not shown). The kcat, at high T7
ssDNA substrate concentrations (based on Vmax)
is 1,400 nucleotides/min/monomer.
The DNase activity of (His)6-ExoX was examined on various
end-labeled ssDNA and dsDNA substrates (Fig.
4). Purified (His)6-ExoX showed efficient release of the terminal nucleotide from 3' ssDNA ends.
95% of all 3' termini were removed in 20 min with a 1:1,900 ratio
(protein monomer to DNA, Fig. 4A). Release of the terminal nucleotide from 5' ssDNA ends was less efficient; nearly 500-fold more
enzyme was required to achieve comparable extent of release of 5' ssDNA
ends (Fig. 4B). In reactions with dsDNA, complete release of
the terminal nucleotide from 3' dsDNA ends (5' overhangs) required
approximately 10-fold more enzyme (Fig. 4C) as compared with
similarly end-labeled ssDNA (Fig. 4A). Nucleolytic activity was barely detected with 5'-labeled dsDNA substrate (Fig.
4D). These results imply that ExoX acts as a 3' to 5'
exonuclease on both ssDNA and dsDNA substrates, with ssDNA more
efficiently attacked than dsDNA.

View larger version (16K):
[in this window]
[in a new window]
|
Fig. 4.
Time course degradation of end-labeled linear
DNA substrates. In panel A, 0.5 µg (0.5 pmol) of 3'
end-labeled ssDNA was incubated with either 8 pg (0.28 fmol) or 4 pg
(0.14 fmol) of (His)6-ExoX. In panel B, 0.5 µg
(0.5 pmol of ends) of 5' end-labeled ssDNA was incubated with either 4 ng (0.15 pmol) or 0.8 ng (0.03 pmol) of (His)6-ExoX. In
panel C, 0.5 µg (0.5 pmol) of 3' end-labeled dsDNA was
incubated with either 80 pg (2.8 fmol) or 40 pg (1.4 fmol) of
(His)6-ExoX. In panel D, 0.5 µg (0.5 pmol) of
5' end-labeled dsDNA was incubated with either 40 ng (1.4 pmol) or 4 ng
(0.14 pmoles) of (His)6-ExoX. All assays were performed
under standard assays conditions described under "Experimental
Procedures."
|
|
A 3' to 5' polarity of digestion was confirmed by gel electrophoresis
of ExoX nuclease reactions with end-labeled ssDNA and dsDNA as
substrate. In these reactions BSA was omitted to allow DNA
electrophoresis without manipulation of the samples after the reaction;
subsequently more enzyme (2-3-fold) was needed for the reactions to go
to completion as compared with the values seen in Fig. 2. A 1:700 molar
ratio of (His)6-ExoX protein to 3' end-labeled ssDNA
(protein monomers: 3' DNA ends) produced a loss of the terminal 3'
label from nearly all the substrate DNA molecules by 20 min, without
detectable shortening of the labeled DNA (Fig.
5A). In contrast, incubation
of (His)6-ExoX with 5' end-labeled ssDNA at a molar ratio
of 1:5 (protein monomers: 5' DNA ends) resulted in progressive
shortening of the labeled DNA with little loss of signal intensity at
the earlier time points (Fig. 5B). By 10 min the ssDNA
molecules either were degraded completely or had become heterogeneous
in size due to asynchronous digestion (Fig. 5B). A 1:100
ratio of (His)6-ExoX protein to 3' end-labeled dsDNA
(protein monomers: 3' DNA ends) also produced a loss of the terminal 3'
label from nearly all the substrate dsDNA molecules by 20 min without
detectable shortening of the labeled DNA (Fig. 5C). Reaction
of a 3-kb 5' end-labeled dsDNA substrate with (His) 6-ExoX
in a 1:2 ratio (protein monomers: 5' DNA ends) resulted in progressive
shortening of the dsDNA molecules from the 3' ends; eventually
shortening from both ends resulted in a 1.5-kb ssDNA product, seen at
10 min.

View larger version (34K):
[in this window]
[in a new window]
|
Fig. 5.
Degradation of end-labeled linear DNA
substrates. In panel A, 9 µg (9 pmol) of 3'
end-labeled ssDNA was incubated with 0.4 ng (13 fmol) of
(His)6-ExoX. In panel B, 5 µg (5 pmol) of 5'
end-labeled ssDNA was incubated with 32 ng (1.1 pmol) of
(His)6-ExoX. In panel C, 4 µg (4 pmol) of 3'
end-labeled dsDNA was incubated with 1.2 ng (42 fmol) of
(His)6-ExoX. In panel D, 4.5 µg (4.5 pmol) of
5' end-labeled dsDNA was incubated with 82 ng (2.8 pmol) of
(His)6-ExoX. All assays were performed under standard
conditions. For each time point, aliquots were removed from the
reaction, quenched on ice with EDTA, and then resolved by agarose gel
electrophoresis as described under "Experimental Procedures."
|
|
These results are consistent with a 3' to 5' polarity of DNA
degradation by ExoX. Furthermore, the degradation by ExoX must be via a
distributive mechanism, because the substrate molecules appear to be
degraded uniformly from the 3' end when substrate is in excess of
enzyme. ExoX must dissociate and rebind to its ssDNA substrate during
cycles of degradation, similar to the mechanism found for the ssDNase
activity associated with RNase T of E. coli and in contrast
to the processive mechanism of DNA degradation exhibited by ssDNA
exonucleases such as exonuclease I (35) and RecJ.2
Competition experiments were performed using 3' end-labeled ssDNA as
the assay substrate and either ssDNA, dsDNA, tRNA, or yeast RNA as
unlabeled competitors. ssDNA proved to be a potent competitor with a
1000-fold excess of cold ssDNA, producing an 80% decrease in released
counts. At the same ratio of substrate to competitor, dsDNA showed a
modest 6% decrease in counts released, whereas both RNA species failed
to compete altogether. These results demonstrate that the affinity of
ExoX for ssDNA is considerably greater than for dsDNA and that RNA is
not a substrate.
ExoX Is Involved in the Repair of UV-induced DNA Damage--
To
determine whether the 3'-5' nuclease activity of ExoX could serve a
biological function we asked whether high copy expression of ExoX could
substitute for ExoI deficiency in UV repair. Plasmid pExoXKS with exoX under lac
promoter control was transformed into both RecJ
ExoI ExoVII and RecJ
ExoVII strains and assayed for UV survival. A plasmid
containing exoX was capable of ameliorating the UV repair
defect of a RecJ ExoI ExoVII
strain, however it had no effect upon the UV sensitivity of a RecJ ExoVII strain (Fig.
6). Neither vector (pBSKS )
nor plasmid pExoXfs, containing a frameshift early in the
exoX coding region, provided any measure of protection.
These results demonstrate that ExoX can specifically compensate for
loss of ExoI, a 3'-5'-specific exonuclease, in vivo.

View larger version (13K):
[in this window]
[in a new window]
|
Fig. 6.
Complementation of ExoI deficiency by
ExoX. STL2701 RecJ ExoI
ExoVII (filled symbols) or STL2348
RecJ ExoVII (open symbols) were
transformed with either pExoXKS ( , ), pExoXfs ( , ), or
pBSKS- ( , ). Transformants were assayed for survival after UV
irradiation as described previously in Viswanathan et al.
(23).
|
|
To confirm a role for ExoX in DNA repair, a null mutant of ExoX was
constructed by homologous recombination of plasmid pExoX into the
E. coli chromosome. This null mutant,
exoX1::npt, carries a precise deletion of the
exoX open reading frame replaced by a cassette containing
the npt gene conferring kanamycin resistance. Using this
null allele of exoX, a series of isogenic
exonuclease-deficient strains were constructed. The exoX
null mutation was added to strains already deficient in one or more of
the other known single-strand exonucleases; RecJ, ExoI, and ExoVII. We
assayed this set of strains for their ability to survive UV irradiation
(Fig. 7). An exoX null mutant
alone had no measurable effect upon UV survival compared with a
Exo+ strain. Similarly, the
exoX1::npt allele added to any other single or
double exonuclease mutant had no effect on UV survival compared with
their respective progenitor strain. However, the exoX1::npt null allele added to a
RecJ ExoI ExoVII mutant
resulted in a strain that was significantly more UV sensitive than the
triple mutant alone, demonstrating a synergistic relationship among
these nucleases with respect to UV survival.

View larger version (18K):
[in this window]
[in a new window]
|
Fig. 7.
ExoX is synergistic with other single-strand
exonucleases in UV repair. Shown are UV survival curves for
E. coli strains both singly and multiply deficient for
exonucleases I, VII, X, and RecJ exonuclease. All strains assayed for
UV survival were derived from the BT199 background. Panel A,
BT199, Exo+ ( ); STL4534, ExoX ( );
STL2331, RecJ ( ); STL4540, RecJ
ExoX ( ); STL4556, ExoVII
RecJ ( ); STL4542, ExoVII
RecJ ExoX ( ); STL4150,
ExoI ExoVII RecJ ( );
STL4535, ExoI ExoVII RecJ
ExoX ( ). Panel B, STL4537,
ExoVII ( ); STL4557, ExoVII
ExoX ( ); STL4555, ExoI
ExoVII ( ); STL4541, ExoI
ExoVII ExoX ( ). Panel C;
STL2694, ExoI ( ); STL4538, ExoI
ExoX ( ); STL2729, ExoI
RecJ ( ); STL4539, ExoI
RecJ ExoX ( ).
|
|
 |
DISCUSSION |
In E. coli, DNA exonucleases play diverse and important
roles in DNA metabolism. The 3'-5' exonucleases associated with the three polymerases (dnaQ, polA, polB)
help maintain genomic fidelity during replication. Exonuclease V,
better known as the RecBCD nuclease, is important for conjugal and
repair recombination of double-strand breaks (36). Exonuclease VIII,
the product of the cryptic Rac prophage, is a component of the RecE
pathway of recombination in E. coli (37). There are also
three known processive ssDNA-specific exonucleases in E. coli, exonuclease I, exonuclease VII, and RecJ exonuclease (36).
These exonucleases catalyze the nucleolytic cleavage of successive
phosphodiester bonds on a ssDNA molecule. Exonuclease I degrades ssDNA
in a 3' to 5' direction (38), RecJ exonuclease has 5' to 3' polarity
(33), and exonuclease VII possesses dual polarity acting from either
DNA end (39). Mutation of one or several of these genes in combination
has pleiotropic effects in DNA repair and recombination in E. coli, including sensitivity to UV irradiation and recombination
defects (34, 40, 41). All three of these exonucleases have been
additionally implicated in the process of methyl-directed mismatch
repair (42, 43). Using in vitro reconstitution experiments
with purified proteins, all three exonucleases can mediate the excision
step of mismatch repair using synthetic mismatch repair substrates (42). In vivo experiments with strains multiply deficient in all three exonucleases have, however, failed to demonstrate a role for
these exonucleases in mismatch repair, suggesting that other, unknown
exonucleases exists in E. coli capable of compensating for
the loss of ExoI, ExoVII, and RecJ (34, 40).
We have demonstrated that the E. coli open reading frame
yobC, which has homology to the DnaQ superfamily, encodes a
25-kDa protein that possesses a potent
Mg2+-dependent ssDNA exonuclease activity.
Accordingly, we have renamed this open reading frame exoX
and its protein product Exonuclease X. The exoX gene appears
to be part of a cistron with another unknown open reading frame denoted
yobB. The genes are separated by 23 nucleotides. Although
exoX does not appear to have any promoter of its own, the
region upstream of yobB contains a 70
promoter-like sequence. Bacterial genome data base searches revealed that both exoX and yobB have protein homologs in
Salmonella typhi; in addition, yobB has a second
homolog in Pseudomonas
aeruginosa.3 No other
strongly homologous proteins were found in the eubacterial data bases,
including the proteobacterial genomes of Haemophilus influenzae and Helicobacter
pylori.4 ExoX did,
however, have significant homology with the DNA polymerase exonuclease
domain of Bacillus subtilis and lesser homology to the DNA
polymerase subunits of various eubacterial species including Chlamydia trachomatis and Staphloccoccus
aureus.
Here we report the purification of a (His)6-ExoX fusion
protein and the characterization of its nuclease activity on various DNA substrates. ExoX degrades DNA in a 3' to 5' direction using a
distributive mechanism of hydrolysis. Therefore, unlike the processive
nuclease ExoI, ExoX undergoes multiple rounds of binding, hydrolysis,
and release to degrade long substrate molecules. Its rapid rate of
ssDNA degradation (1,400 nucleotides ssDNA/min/monomer) is due in part
to the high affinity of the enzyme (Km = 1.7 nM) for ssDNA. Although capable of degrading both ssDNA and
dsDNA molecules, ExoX has higher affinity for ssDNA ends as judged by
the extent of degradation of various substrates and by competition
experiments. The need for high enzyme to DNA stoichiometry for duplex
DNA degradation may mean that the duplex DNA binding step is slow
relative to ssDNA binding. The mechanism by which ExoX binds and
catalyzes phosphodiester bond cleavage of either the single-strand or
duplex DNA end may be revealed by more biochemical and structural information.
Previously we demonstrated that RecJ exonuclease, ExoI, and ExoVII are
involved in a redundant fashion in the repair of UV-induced lesions
(34). We have proposed that these exonucleases act during recombinational repair of lesions that block replication. Here we have
demonstrated that ExoX can specifically compensate for UV repair
defects associated with the loss of ExoI, itself a potent 3'-5'
exonuclease. This result correlates well with the biochemical characterization of the enzyme. The fact that ExoX could only partially
compensate for ExoI even when expressed in high copy may reflect the
disparity between a processive nuclease such as ExoI and a distributive
nuclease like ExoX.
Alone, an exoX null mutant did not appear to affect
the UV survival of E. coli. However, in combination with
mutations in RecJ, ExoI, and ExoVII, an exoX mutation
greatly attenuated UV survival. These results demonstrate that
exonuclease X can play a role in DNA repair and suggests that all four
exonucleases likely share a redundant function. Given that the role of
ExoX in repair was only evident when three other exonucleases were
removed, ExoX clearly plays a minor role in UV repair. This is similar
to ExoI (34) and suggests that 3'-5' exonucleases, ExoI and ExoX, are less important for UV repair than the 5' to 3' exonuclease activity of
RecJ and ExoVII. The UV sensitivity of the quadruple mutant is extreme,
approximating that of RecA, in which recombination is completely
blocked. We have suggested that ssDNA degradation is required for
efficient RecA-dependent recombinational repair to create
presynaptic recombinational intermediates and to extend heteroduplex
regions post-synaptically (34, 44). Although no individual ssDNA
exonuclease is indispensable in DNA repair, a redundant function
specified by RecJ, ExoI, ExoVII, and ExoX is essential for UV
repair and potentially other cellular processes.
 |
ACKNOWLEDGEMENTS |
We thank the Molecular Biology Core Facility
at Dana Farber Cancer Institute for mass spectrometry of purified ExoX
and Susan Rosenberg for constructing and providing us the
xseA18::amp allele. We also like to
thank Victor De Lorenzo for creating and providing to us the
site-specific resolution system used in construction of the
exoX knockout.
 |
FOOTNOTES |
*
This work was supported by Public Health Service Grants T32
GM07122 (to M. V.) and RO1 GM43889.The costs of publication of this
article were defrayed in part by the
payment of page charges. The article
must therefore be hereby marked
"advertisement" in accordance with 18 U.S.C. Section
1734 solely to indicate this fact.
To whom correspondence should be addressed: Dept. of Biology and
Rosenstiel Basic Medical Sciences Research Center, Brandeis University,
Waltham, MA 02254-9110. Tel.: 781-736-2497; Fax: 781-736-2405; E-mail:
lovett@hydra.rose.brandeis.edu.
3
Sequence data for S. typhi and
P. aeruginosa were obtained from The Institute for Genomic Research.
4
The Institute for Genomic Research.
2
S. T. Lovett and R. D. Kolodner, unpublished observation.
 |
ABBREVIATIONS |
The abbreviations used are:
ExoI, exonuclease I;
ExoVII, exonuclease VII;
ExoX, exonuclease X;
ss, single-strand;
ds, double strand;
DTT, dithiothreitol;
BSA, bovine serum albumin;
PCR, polymerase chain reaction;
kb, kilobase(s).
 |
REFERENCES |
| 1.
|
Koonin, E. V.
(1997)
Curr. Biol.
7,
604-606
|
| 2.
|
Moser, M. J.,
Holley, W. R.,
Chatterjee, A.,
and Mian, I. S.
(1997)
Nucleic Acids Res.
25,
5110-5118[Abstract/Free Full Text]
|
| 3.
|
Zhang, X.,
Zhu, L.,
and Deutscher, M. P.
(1998)
J. Bacteriol.
180,
2779-2781[Abstract/Free Full Text]
|
| 4.
|
Mian, I. S.
(1997)
Nucleic Acids Res.
25,
3187-3195[Abstract/Free Full Text]
|
| 5.
|
Bernad, A.,
Blanco, L.,
Lazaro, J. M.,
Martin, G.,
and Salas, M.
(1989)
Cell
59,
219-228[CrossRef][Medline]
[Order article via Infotrieve]
|
| 6.
|
Freemont, P. S.,
Friedman, J. M.,
Beese, L. S.,
Sanderson, M. R.,
and Steitz, T. A.
(1988)
Proc. Natl. Acad. Sci. U. S. A.
85,
8924-8928[Abstract/Free Full Text]
|
| 7.
|
Derbyshire, V.,
Freemont, P. S.,
Sanderson, M. R.,
Beese, L.,
Friedman, J. M.,
Joyce, C. M.,
and Steitz, T. A.
(1988)
Science
240,
199-201[Abstract/Free Full Text]
|
| 8.
|
Beese, L. S.,
and Steitz, T. A.
(1991)
EMBO J.
10,
25-33[Medline]
[Order article via Infotrieve]
|
| 9.
|
Beese, L. S.,
Derbyshire, V.,
and Steitz, T. A.
(1993)
Science
260,
352-355[Abstract/Free Full Text]
|
| 10.
|
Wang, J., Yu, P.,
Lin, T. C.,
Konigsberg, W. H.,
and Steitz, T. A.
(1996)
Biochemistry
35,
8110-8119[CrossRef][Medline]
[Order article via Infotrieve]
|
| 11.
|
Huang, S.,
Li, B.,
Gray, M. D.,
Oshima, J.,
Mian, I. S.,
and Campisi, J.
(1998)
Nat. Genet.
20,
114-116[CrossRef][Medline]
[Order article via Infotrieve]
|
| 12.
|
Kamath-Loeb, A. S.,
Shen, J. C.,
Loeb, L. A.,
and Fry, M.
(1998)
J. Biol. Chem.
273,
34145-34150[Abstract/Free Full Text]
|
| 13.
|
Shen, J. C.,
Gray, M. D.,
Oshima, J.,
Kamath-Loeb, A. S.,
Fry, M.,
and Loeb, L. A.
(1998)
J. Biol. Chem.
273,
34139-34144[Abstract/Free Full Text]
|
| 14.
|
Yu, C. E.,
Oshima, J.,
Fu, Y. H.,
Wijsman, E. M.,
Hisama, F.,
Alisch, R.,
Matthews, S.,
Nakura, J.,
Miki, T.,
Ouais, S.,
Martin, G. M.,
Mulligan, J.,
and Schellenberg, G. D.
(1996)
Science
272,
258-262[Abstract]
|
| 15.
|
Suzuki, N.,
Shimamoto, A.,
Imamura, O.,
Kuromitsu, J.,
Kitao, S.,
Goto, M.,
and Furuichi, Y.
(1997)
Nucleic Acids Res.
25,
2973-2978[Abstract/Free Full Text]
|
| 16.
|
Gray, M. D.,
Shen, J. C.,
Kamath-Loeb, A. S.,
Blank, A.,
Sopher, B. L.,
Martin, G. M.,
Oshima, J.,
and Loeb, L. A.
(1997)
Nat. Genet.
17,
100-103[CrossRef][Medline]
[Order article via Infotrieve]
|
| 17.
|
Mushegian, A. R.,
Bassett, D. E., Jr.,
Boguski, M. S.,
Bork, P.,
and Koonin, E. V.
(1997)
Proc. Natl. Acad. Sci. U. S. A.
94,
5831-5836[Abstract/Free Full Text]
|
| 18.
|
Morozov, V.,
Mushegian, A. R.,
Koonin, E. V.,
and Bork, P.
(1997)
Trends Biochem. Sci.
22,
417-418[CrossRef][Medline]
[Order article via Infotrieve]
|
| 19.
|
Li, Z.,
and Deutscher, M. P.
(1995)
Proc. Natl. Acad. Sci. U. S. A.
92,
6883-6886[Abstract/Free Full Text]
|
| 20.
|
Deutscher, M. P.,
Marlor, C. W.,
and Zaniewski, R.
(1985)
Proc. Natl. Acad. Sci. U. S. A.
82,
6427-6430[Abstract/Free Full Text]
|
| 21.
|
Deutscher, M. P.,
and Marlor, C. W.
(1985)
J. Biol. Chem.
260,
7067-7071[Abstract/Free Full Text]
|
| 22.
|
Viswanathan, M.,
Dower, K. W.,
and Lovett, S. T.
(1998)
J. Biol. Chem.
273,
35126-35131[Abstract/Free Full Text]
|
| 23.
|
Viswanathan, M.,
Lanjuin, A.,
and Lovett, S. T.
(1999)
Genetics
151,
929-934[Abstract/Free Full Text]
|
| 24.
|
Kristensen, C. S.,
Eberl, L.,
Sanchez-Romero, J. M.,
Givskov, M.,
Molin, S.,
and De Lorenzo, V.
(1995)
J. Bacteriol.
177,
52-68[Abstract/Free Full Text]
|
| 25.
|
Haggerty, T. J.,
and Lovett, S. T.
(1997)
J. Bacteriol.
179,
6705-6713[Abstract/Free Full Text]
|
| 26.
|
Chung, C. T.,
Niemela, S. L.,
and Miller, R. H.
(1989)
Proc. Natl. Acad. Sci. U. S. A.
86,
2172-2175[Abstract/Free Full Text]
|
| 27.
|
Studier, F. W.,
and Moffatt, B. A.
(1986)
J. Mol. Biol.
189,
113-130[CrossRef][Medline]
[Order article via Infotrieve]
|
| 28.
|
Horii, Z.,
and Clark, A. J.
(1973)
J. Mol. Biol.
80,
327-344[CrossRef][Medline]
[Order article via Infotrieve]
|
| 29.
|
Southern, E. M.
(1975)
J. Mol. Biol.
98,
503-517[CrossRef][Medline]
[Order article via Infotrieve]
|
| 30.
|
Miller, J. H.
(1992)
A Short Course in Bacterial Genetics
, pp. 268-274, Cold Spring Harbor Laboratory, Plainview, NY
|
| 31.
|
Bradford, M. M.
(1976)
Anal. Biochem.
72,
248-254[CrossRef][Medline]
[Order article via Infotrieve]
|
| 32.
|
Ausubel, F. A.,
Brent, R.,
Kingston, R. E.,
Moore, D. D.,
Seidman, J. G.,
Smith, J. A.,
and Struhl, K.
(1989)
Short Protocols in Molecular Biology
, Greene Publishing and Wiley-Interscience, New York
|
| 33.
|
Lovett, S. T.,
and Kolodner, R. D.
(1989)
Proc. Natl. Acad. Sci. U. S. A.
86,
2627-2631[Abstract/Free Full Text]
|
| 34.
|
Viswanathan, M.,
and Lovett, S. T.
(1998)
Genetics
149,
7-16[Abstract/Free Full Text]
|
| 35.
|
Thomas, K. R.,
and Olivera, B. M.
(1978)
J. Biol. Chem.
253,
424-429[Abstract/Free Full Text]
|
| 36.
|
Kowalczykowski, S. C.,
Dixon, D. A.,
Eggleston, A. K.,
Lauder, S. D.,
and Rehrauer, W. M.
(1994)
Microbiol. Rev.
58,
401-465[Abstract/Free Full Text]
|
| 37.
|
Kolodner, R.,
Hall, S. D.,
and Luisi-DeLuca, C.
(1994)
Mol. Microbiol.
11,
23-30[Medline]
[Order article via Infotrieve]
|
| 38.
|
Lehman, I. R.,
and Nussbaum, A. L.
(1964)
J. Biol. Chem.
239,
2628-2636[Free Full Text]
|
| 39.
|
Chase, J. W.,
and Richardson, C. C.
(1974)
J. Biol. Chem.
249,
4553-4561[Abstract/Free Full Text]
|
| 40.
|
Harris, R. S.,
Ross, K. J.,
Lombardo, M. J.,
and Rosenberg, S. M.
(1998)
J. Bacteriol.
180,
989-993[Abstract/Free Full Text]
|
| 41.
|
Miesel, L.,
and Roth, J. R.
(1996)
J. Bacteriol.
178,
3146-3155[Abstract/Free Full Text]
|
| 42.
|
Cooper, D. L.,
Lahue, R. S.,
and Modrich, P.
(1993)
J. Biol. Chem.
268,
11823-11829[Abstract/Free Full Text]
|
| 43.
|
Grilley, M.,
Griffith, J.,
and Modrich, P.
(1993)
J. Biol. Chem.
268,
11830-11837[Abstract/Free Full Text]
|
| 44.
|
Corrette-Bennett, S. E.,
and Lovett, S. T.
(1995)
J. Biol. Chem.
270,
6881-6885[Abstract/Free Full Text]
|
Copyright © 1999 by The American Society for Biochemistry and Molecular Biology, Inc.

CiteULike Complore Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
V. Palchevskiy and S. E. Finkel
A Role for Single-Stranded Exonucleases in the Use of DNA as a Nutrient
J. Bacteriol.,
June 1, 2009;
191(11):
3712 - 3716.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. A. Larrea, I. M. Pedroso, A. Malhotra, and R. S. Myers
Identification of two conserved aspartic acid residues required for DNA digestion by a novel thermophilic Exonuclease VII in Thermotoga maritima
Nucleic Acids Res.,
October 1, 2008;
36(18):
5992 - 6003.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. Serment-Guerrero, M. Brena-Valle, and J. J. Espinosa-Aguirre
In vivo role of Escherichia coli single-strand exonucleases in SOS induction by gamma radiation
Mutagenesis,
July 1, 2008;
23(4):
317 - 323.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
B. Thoms, I. Borchers, and W. Wackernagel
Effects of Single-Strand DNases ExoI, RecJ, ExoVII, and SbcCD on Homologous Recombination of recBCD+ Strains of Escherichia coli and Roles of SbcB15 and XonA2 ExoI Mutant Enzymes
J. Bacteriol.,
January 1, 2008;
190(1):
179 - 192.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
B. E. Dutra, V. A. Sutera Jr., and S. T. Lovett
RecA-independent recombination is efficient but limited by exonucleases
PNAS,
January 2, 2007;
104(1):
216 - 221.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. M. Kupsco, M.-J. Wu, W. F. Marzluff, R. Thapar, and R. J. Duronio
Genetic and biochemical characterization of Drosophila Snipper: A promiscuous member of the metazoan 3'hExo/ERI-1 family of 3' to 5' exonucleases
RNA,
December 1, 2006;
12(12):
2103 - 2117.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. N. Hersh, L. D. Morales, K. J. Ross, and S. M. Rosenberg
Single-Strand-Specific Exonucleases Prevent Frameshift Mutagenesis by Suppressing SOS Induction and the Action of DinB/DNA Polymerase IV in Growing Cells.
J. Bacteriol.,
April 1, 2006;
188(7):
2336 - 2342.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. Thermic
Functions of Multiple Exonucleases Are Essential for Cell Viability, DNA Repair and Homologous Recombination in recD Mutants of Escherichia coli
Genetics,
April 1, 2006;
172(4):
2057 - 2069.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D.-H. Yang, J. G. de Jong, A. Makhmoudova, B. M. Arif, and P. J. Krell
Choristoneura fumiferana nucleopolyhedrovirus encodes a functional 3'-5' exonuclease
J. Gen. Virol.,
December 1, 2004;
85(12):
3569 - 3573.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
V. V. Feschenko, L. A. Rajman, and S. T. Lovett
Stabilization of perfect and imperfect tandem repeats by single-strand DNA exonucleases
PNAS,
February 4, 2003;
100(3):
1134 - 1139.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
V. Burdett, C. Baitinger, M. Viswanathan, S. T. Lovett, and P. Modrich
In vivo requirement for RecJ, ExoVII, ExoI, and ExoX in methyl-directed mismatch repair
PNAS,
May 24, 2001;
(2001)
121183298.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. J. Mazur and F. W. Perrino
Structure and Expression of the TREX1 and TREX2 3'right-arrow5' Exonuclease Genes
J. Biol. Chem.,
April 27, 2001;
276(18):
14718 - 14727.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. J. Mazur and F. W. Perrino
Excision of 3' Termini by the Trex1 and TREX2 3'right-arrow5' Exonucleases. CHARACTERIZATION OF THE RECOMBINANT PROTEINS
J. Biol. Chem.,
May 11, 2001;
276(20):
17022 - 17029.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Viswanathan, V. Burdett, C. Baitinger, P. Modrich, and S. T. Lovett
Redundant Exonuclease Involvement in Escherichia coli Methyl-directed Mismatch Repair
J. Biol. Chem.,
August 10, 2001;
276(33):
31053 - 31058.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
V. Burdett, C. Baitinger, M. Viswanathan, S. T. Lovett, and P. Modrich
In vivo requirement for RecJ, ExoVII, ExoI, and ExoX in methyl-directed mismatch repair
PNAS,
June 5, 2001;
98(12):
6765 - 6770.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Copyright © 1999 by the American Society for Biochemistry and Molecular Biology.
|
Advertisement
Advertisement
|